骨髓增生-话题@MedSci

#骨髓增生#

95篇内容 | 2320人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1821797, encodeId=5a561821e971e, content=<a href='/topic/show?id=d1ba10196122' target=_blank style='color:#2F92EE;'>#骨髓增生#</a>, objectTitle=2019 西班牙指南：靶向深度测序在骨髓增生异常综合征和慢性粒单核细胞白血病中的应用, objectType=article, longId=183147, objectId=cbf918314e73, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cbf918314e73, replyNumber=0, likeNumber=51, createdTime=2020-03-28, rootId=0, userName=fengyqf, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cbf918314e73, moduleTitle=2019 西班牙指南：靶向深度测序在骨髓增生异常综合征和慢性粒单核细胞白血病中的应用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cbf918314e73)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1821799, encodeId=90751821e997b, content=<a href='/topic/show?id=d1ba10196122' target=_blank style='color:#2F92EE;'>#骨髓增生#</a>, objectTitle=病例：阿扎胞苷有效治疗1例再生障碍性贫血转骨髓增生异常综合征, objectType=article, longId=184423, objectId=386018442350, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=386018442350, replyNumber=0, likeNumber=73, createdTime=2020-04-14, rootId=0, userName=fengyqf, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=386018442350, moduleTitle=病例：阿扎胞苷有效治疗1例再生障碍性贫血转骨髓增生异常综合征, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=386018442350)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1821793, encodeId=4e4c1821e937e, content=<a href='/topic/show?id=d1ba10196122' target=_blank style='color:#2F92EE;'>#骨髓增生#</a>, objectTitle=NCCN临床实践指南：骨髓增生异常综合征（2020.V1）, objectType=article, longId=178712, objectId=630e1e8712c4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=630e1e8712c4, replyNumber=0, likeNumber=38, createdTime=2020-05-16, rootId=0, userName=fengyqf, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=630e1e8712c4, moduleTitle=NCCN临床实践指南：骨髓增生异常综合征（2020.V1）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=630e1e8712c4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1821795, encodeId=57db1821e950d, content=<a href='/topic/show?id=d1ba10196122' target=_blank style='color:#2F92EE;'>#骨髓增生#</a>, objectTitle=Sci Transl Med：冷泉港实验室华人科学家发现改善骨髓增生异常综合症新疗法, objectType=article, longId=180639, objectId=9179180639cc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9179180639cc, replyNumber=0, likeNumber=70, createdTime=2020-04-02, rootId=0, userName=fengyqf, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9179180639cc, moduleTitle=Sci Transl Med：冷泉港实验室华人科学家发现改善骨髓增生异常综合症新疗法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9179180639cc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1821803, encodeId=8dd318218039d, content=<a href='/topic/show?id=d1ba10196122' target=_blank style='color:#2F92EE;'>#骨髓增生#</a>, objectTitle=Lancet haematol：Enasidenib治疗IDH2突变型骨髓增生异常综合征, objectType=article, longId=189592, objectId=c3fe18959242, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c3fe18959242, replyNumber=0, likeNumber=71, createdTime=2021-01-15, rootId=0, userName=fengyqf, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c3fe18959242, moduleTitle=Lancet haematol：Enasidenib治疗IDH2突变型骨髓增生异常综合征, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c3fe18959242)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1821804, encodeId=21e5182180486, content=<a href='/topic/show?id=d1ba10196122' target=_blank style='color:#2F92EE;'>#骨髓增生#</a>, objectTitle=FDA批准Reblozyl治疗骨髓增生异常综合症相关的贫血, objectType=article, longId=191464, objectId=43e019146416, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=43e019146416, replyNumber=0, likeNumber=65, createdTime=2021-02-04, rootId=0, userName=fengyqf, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=43e019146416, moduleTitle=FDA批准Reblozyl治疗骨髓增生异常综合症相关的贫血, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=43e019146416)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1821798, encodeId=0e9c1821e985f, content=<a href='/topic/show?id=d1ba10196122' target=_blank style='color:#2F92EE;'>#骨髓增生#</a>, objectTitle=Blood：HDAC11抑制剂，骨髓增生性肿瘤的新选择, objectType=article, longId=183497, objectId=462318349ea8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=462318349ea8, replyNumber=0, likeNumber=74, createdTime=2020-01-31, rootId=0, userName=fengyqf, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=462318349ea8, moduleTitle=Blood：HDAC11抑制剂，骨髓增生性肿瘤的新选择, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=462318349ea8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1821802, encodeId=8389182180289, content=<a href='/topic/show?id=d1ba10196122' target=_blank style='color:#2F92EE;'>#骨髓增生#</a>, objectTitle=JSH实践指南：血液恶性肿瘤—Ⅰ.白血病-6:骨髓增生异常综合征, objectType=article, longId=188777, objectId=28ae188e771f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=28ae188e771f, replyNumber=0, likeNumber=0, createdTime=2021-01-04, rootId=0, userName=fengyqf, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=28ae188e771f, moduleTitle=JSH实践指南：血液恶性肿瘤—Ⅰ.白血病-6:骨髓增生异常综合征, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=28ae188e771f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1821791, encodeId=a69b1821e918b, content=<a href='/topic/show?id=d1ba10196122' target=_blank style='color:#2F92EE;'>#骨髓增生#</a>, objectTitle=Blood：华法林或损害造血功能！科学家发现华法林可能改变骨髓微环境，与老年人骨髓增生异常综合征的风险增加有关, objectType=article, longId=167273, objectId=dd0016e27301, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dd0016e27301, replyNumber=0, likeNumber=125, createdTime=2019-08-03, rootId=0, userName=fengyqf, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dd0016e27301, moduleTitle=Blood：华法林或损害造血功能！科学家发现华法林可能改变骨髓微环境，与老年人骨髓增生异常综合征的风险增加有关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dd0016e27301)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1821796, encodeId=b02d1821e9698, content=<a href='/topic/show?id=d1ba10196122' target=_blank style='color:#2F92EE;'>#骨髓增生#</a>, objectTitle=Blood：巨核细胞钙网蛋白与SOCE的互作异常促进骨髓增生性肿瘤的发生发展, objectType=article, longId=182023, objectId=7fa61820234e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7fa61820234e, replyNumber=0, likeNumber=93, createdTime=2019-12-02, rootId=0, userName=fengyqf, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7fa61820234e, moduleTitle=Blood：巨核细胞钙网蛋白与SOCE的互作异常促进骨髓增生性肿瘤的发生发展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7fa61820234e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1821787, encodeId=c9701821e8786, content=<a href='/topic/show?id=d1ba10196122' target=_blank style='color:#2F92EE;'>#骨髓增生#</a>, objectTitle=Blood：重编程与骨髓增生异常综合征的克隆进化阶段, objectType=article, longId=164914, objectId=ad071649145a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ad071649145a, replyNumber=0, likeNumber=84, createdTime=2019-07-30, rootId=0, userName=fengyqf, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ad071649145a, moduleTitle=Blood：重编程与骨髓增生异常综合征的克隆进化阶段, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ad071649145a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1821788, encodeId=b7d11821e88e1, content=<a href='/topic/show?id=d1ba10196122' target=_blank style='color:#2F92EE;'>#骨髓增生#</a>, objectTitle=Lancet Haemat：Guadecitabine用于中高危骨髓增生异常综合征患者的疗效和安全性, objectType=article, longId=165382, objectId=9da8165382e2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9da8165382e2, replyNumber=0, likeNumber=64, createdTime=2019-07-29, rootId=0, userName=fengyqf, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9da8165382e2, moduleTitle=Lancet Haemat：Guadecitabine用于中高危骨髓增生异常综合征患者的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9da8165382e2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1821782, encodeId=a9401821e8257, content=<a href='/topic/show?id=d1ba10196122' target=_blank style='color:#2F92EE;'>#骨髓增生#</a>, objectTitle=ARCH PATHOL LAB MED：骨髓增生异常综合征患者中性粒细胞中的Howell-Jolly体样包涵体：一种新的相关性, objectType=article, longId=159514, objectId=e19815951428, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e19815951428, replyNumber=0, likeNumber=95, createdTime=2019-06-15, rootId=0, userName=fengyqf, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e19815951428, moduleTitle=ARCH PATHOL LAB MED：骨髓增生异常综合征患者中性粒细胞中的Howell-Jolly体样包涵体：一种新的相关性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e19815951428)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1821794, encodeId=fc941821e94d7, content=<a href='/topic/show?id=d1ba10196122' target=_blank style='color:#2F92EE;'>#骨髓增生#</a>, objectTitle=骨髓增生异常综合征的治疗：ASTX727已获美国FDA的孤儿药物指定, objectType=article, longId=178844, objectId=61061e884412, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=61061e884412, replyNumber=0, likeNumber=58, createdTime=2020-08-03, rootId=0, userName=fengyqf, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=61061e884412, moduleTitle=骨髓增生异常综合征的治疗：ASTX727已获美国FDA的孤儿药物指定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=61061e884412)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1821786, encodeId=fcb21821e8695, content=<a href='/topic/show?id=d1ba10196122' target=_blank style='color:#2F92EE;'>#骨髓增生#</a>, objectTitle=骨髓增生异常综合征中国诊断与治疗指南（2019年）, objectType=article, longId=164582, objectId=555c1645822f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=555c1645822f, replyNumber=0, likeNumber=67, createdTime=2019-05-30, rootId=0, userName=fengyqf, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=555c1645822f, moduleTitle=骨髓增生异常综合征中国诊断与治疗指南（2019年）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=555c1645822f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1821789, encodeId=648b1821e89e7, content=<a href='/topic/show?id=d1ba10196122' target=_blank style='color:#2F92EE;'>#骨髓增生#</a>, objectTitle=Lancet Haematology.：Guadecitabine用于中高危骨髓增生异常综合征, objectType=article, longId=165485, objectId=0adb1654850e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0adb1654850e, replyNumber=0, likeNumber=98, createdTime=2019-06-28, rootId=0, userName=fengyqf, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0adb1654850e, moduleTitle=Lancet Haematology.：Guadecitabine用于中高危骨髓增生异常综合征, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0adb1654850e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1821778, encodeId=f1881821e784d, content=<a href='/topic/show?id=d1ba10196122' target=_blank style='color:#2F92EE;'>#骨髓增生#</a>, objectTitle=Blood：HMA治疗失败后，应如何治疗骨髓增生异常综合征？, objectType=article, longId=157421, objectId=a94e15e42118, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a94e15e42118, replyNumber=0, likeNumber=84, createdTime=2019-05-31, rootId=0, userName=fengyqf, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a94e15e42118, moduleTitle=Blood：HMA治疗失败后，应如何治疗骨髓增生异常综合征？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a94e15e42118)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1821780, encodeId=f9911821e8092, content=<a href='/topic/show?id=d1ba10196122' target=_blank style='color:#2F92EE;'>#骨髓增生#</a>, objectTitle=INT J LAB HEMATOL：隐性骨髓增生异常综合征(MDS):一项确定或排除病因不明的贫血患者中MDS的前瞻性研究, objectType=article, longId=159068, objectId=21bc15906861, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=21bc15906861, replyNumber=0, likeNumber=61, createdTime=2019-10-14, rootId=0, userName=fengyqf, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=21bc15906861, moduleTitle=INT J LAB HEMATOL：隐性骨髓增生异常综合征(MDS):一项确定或排除病因不明的贫血患者中MDS的前瞻性研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=21bc15906861)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1821792, encodeId=64af1821e9222, content=<a href='/topic/show?id=d1ba10196122' target=_blank style='color:#2F92EE;'>#骨髓增生#</a>, objectTitle=IJLH：隐性骨髓增生异常综合征(MDS)-用于确定或排除病因不明的贫血患者的MDS, objectType=article, longId=167568, objectId=817016e5685e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=817016e5685e, replyNumber=0, likeNumber=95, createdTime=2019-12-11, rootId=0, userName=fengyqf, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=817016e5685e, moduleTitle=IJLH：隐性骨髓增生异常综合征(MDS)-用于确定或排除病因不明的贫血患者的MDS, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=817016e5685e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1821785, encodeId=dd421821e85ed, content=<a href='/topic/show?id=d1ba10196122' target=_blank style='color:#2F92EE;'>#骨髓增生#</a>, objectTitle=Blood：CDK 6与骨髓增生性肿瘤, objectType=article, longId=164245, objectId=7e4816424526, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7e4816424526, replyNumber=0, likeNumber=61, createdTime=2020-02-17, rootId=0, userName=fengyqf, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7e4816424526, moduleTitle=Blood：CDK 6与骨髓增生性肿瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7e4816424526)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

骨髓增生

2020-05-29

fengyqf (审核中...)

前往app查看评论内容

#骨髓增生#

2019 西班牙指南：靶向深度测序在骨髓增生异常综合征和慢性粒单核细胞白血病中的应用

2020-03-28

fengyqf (审核中...)

前往app查看评论内容

#骨髓增生#

病例：阿扎胞苷有效治疗1例再生障碍性贫血转骨髓增生异常综合征

2020-04-14

fengyqf (审核中...)

前往app查看评论内容

#骨髓增生#

NCCN临床实践指南：骨髓增生异常综合征（2020.V1）

2020-05-16

fengyqf (审核中...)

前往app查看评论内容

#骨髓增生#

Sci Transl Med：冷泉港实验室华人科学家发现改善骨髓增生异常综合症新疗法

2020-04-02

fengyqf (审核中...)

前往app查看评论内容

#骨髓增生#

Lancet haematol：Enasidenib治疗IDH2突变型骨髓增生异常综合征

2021-01-15

fengyqf (审核中...)

前往app查看评论内容

#骨髓增生#

FDA批准Reblozyl治疗骨髓增生异常综合症相关的贫血

2021-02-04

fengyqf (审核中...)

前往app查看评论内容

#骨髓增生#

Blood：HDAC11抑制剂，骨髓增生性肿瘤的新选择

2020-01-31

fengyqf (审核中...)

前往app查看评论内容

#骨髓增生#

JSH实践指南：血液恶性肿瘤—Ⅰ.白血病-6:骨髓增生异常综合征

2021-01-04

fengyqf (审核中...)

前往app查看评论内容

#骨髓增生#

Blood：华法林或损害造血功能！科学家发现华法林可能改变骨髓微环境，与老年人骨髓增生异常综合征的风险增加有关

2019-08-03

fengyqf (审核中...)

前往app查看评论内容

#骨髓增生#

Blood：巨核细胞钙网蛋白与SOCE的互作异常促进骨髓增生性肿瘤的发生发展

2019-12-02

fengyqf (审核中...)

前往app查看评论内容

#骨髓增生#

Blood：重编程与骨髓增生异常综合征的克隆进化阶段

2019-07-30

fengyqf (审核中...)

前往app查看评论内容

#骨髓增生#

Lancet Haemat：Guadecitabine用于中高危骨髓增生异常综合征患者的疗效和安全性

2019-07-29

fengyqf (审核中...)

前往app查看评论内容

#骨髓增生#

ARCH PATHOL LAB MED：骨髓增生异常综合征患者中性粒细胞中的Howell-Jolly体样包涵体：一种新的相关性

2019-06-15

fengyqf (审核中...)

前往app查看评论内容

#骨髓增生#

骨髓增生异常综合征的治疗：ASTX727已获美国FDA的孤儿药物指定

2020-08-03

fengyqf (审核中...)

前往app查看评论内容

#骨髓增生#

骨髓增生异常综合征中国诊断与治疗指南（2019年）

2019-05-30

fengyqf (审核中...)

前往app查看评论内容

#骨髓增生#

Lancet Haematology.：Guadecitabine用于中高危骨髓增生异常综合征

2019-06-28

fengyqf (审核中...)

前往app查看评论内容

#骨髓增生#

Blood：HMA治疗失败后，应如何治疗骨髓增生异常综合征？

2019-05-31

fengyqf (审核中...)

前往app查看评论内容

#骨髓增生#

INT J LAB HEMATOL：隐性骨髓增生异常综合征(MDS):一项确定或排除病因不明的贫血患者中MDS的前瞻性研究

2019-10-14

fengyqf (审核中...)

前往app查看评论内容

#骨髓增生#

IJLH：隐性骨髓增生异常综合征(MDS)-用于确定或排除病因不明的贫血患者的MDS

2019-12-11

fengyqf (审核中...)

前往app查看评论内容

#骨髓增生#

Blood：CDK 6与骨髓增生性肿瘤

2020-02-17

科室
- - 订阅+
  - 更多科室
工具
服务